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Age at Menarche and Cardiometabolic Health: A Sibling Analysis in
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Background-—Previous studies of age at menarche and cardiometabolic health report conﬂicting ﬁndings, and only a few could
account for childhood characteristics. We aimed to estimate the associations of age at menarche with cardiovascular risk factors in
unrelated women and within sister groups, under the assumption that within-sibship estimates will be better adjusted for shared
genetics and early life environment.
Methods and Results-—Our study included 7770 women, from 5984 sibships, participating in the GS:SFHS (Generation Scotland:
Scottish Family Health Study). We used ﬁxed- and between-effects linear regression to estimate the associations within sister
groups and between unrelated individuals, respectively. Within sibships, the mean difference between sisters with early menarche
(≤11 years) and sisters with menarche at 12 to 13 years was 1.73 mm Hg (95% conﬁdence interval [CI], 0.41 to 3.86) for
systolic blood pressure, 1.26 mm Hg (95% CI, 0.02 to 2.55) for diastolic blood pressure, 0.06 nmol/L (95% CI, 0.11 to
0.02) for high-density lipoprotein, 0.20 nmol/L (95% CI, 0.08–0.32) for non–high-density lipoprotein, 0.34% (95% CI, 1.98 to
1.30) for glucose, 1.60 kg/m2 (95% CI, 0.92–2.28) for body mass index, and 2.75 cm (95% CI, 1.06–4.44) for waist circumference.
There was weak evidence of associations between later menarche (14–15 or ≥16 years) and lower body mass index, waist
circumference, and blood pressure. We found no strong evidence that estimates from within- and between-sibship analyses
differed (all P values >0.1). The associations with other cardiovascular risk factors were attenuated after adjustment for adult body
mass index.
Conclusions-—Our results suggest that confounding by shared familial characteristics is unlikely to be a major driver of the
association between early menarche and adverse cardiometabolic health but do not exclude confounding by individual-level
characteristics. ( J Am Heart Assoc. 2018;7:e007780. DOI: 10.1161/JAHA.117.007780.)
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E arly menarche is associated with reduced insulinsensitivity and higher glucose,1–9 higher triglycerides and
cholesterol levels,2,6,10 higher blood pressure,4,5,11,12 and greater
waist circumference and body mass index (BMI).4,5,13–15 In
line with these ﬁndings, there is some but less consistent
evidence of an association between age at menarche and
cardiovascular disease (CVD) events.12,16–18 Mendelian
randomization studies suggest causal effects of greater
childhood BMI on early timing of menarche and of earlier
menarche on higher adult BMI and CVD risk,19,20 although
genetic pleiotropy may at least partially explain these
ﬁndings.12 The few observational analyses that were able to
adjust for childhood adiposity found that the associations of
age at menarche with adult cardiometabolic health were
virtually completely attenuated, suggesting that childhood
adiposity is a key confounder.4,14 However, studies from
populations in which childhood obesity is less prevalent,
such as Korea,5,7,8 Bangladesh,6 China,9 and Brazil,10 also
indicate an association between early menarche and worse
cardiometabolic health.
Sibling studies controls for confounding (measured and
unmeasured) by characteristics shared within families.21,22
The underlying assumption of this approach is that siblings
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share identical or very similar early life environments in
addition to, on average, half of their genetic architecture—
often referred to as ﬁxed family characteristics—and thus
individual-level confounding by characteristics that vary
between siblings will be minimal.23 This approach has been
used to explore the associations of intrauterine exposures,
such as higher maternal BMI and gestational diabetes, with
later offspring adiposity24 and of maternal age with perinatal
outcomes,25 for which the key concern is family-level
socioeconomic confounding. Where the assumptions of the
within-sibship analysis are likely to hold, differences between
associations seen in unrelated individuals and within sibling
groups are interpreted as being due to residual individual-
person confounding in the former, whereas similarities in
ﬁndings suggest that associations are not driven by shared
genetic or early life environment.
In this study, we estimated and compared the associations
of age at menarche with measures of cardiometabolic health
in unrelated women and within sister groups. Our assumption
was that adiposity and lifestyle characteristics before menar-
che (ie, up to age 10 years) were likely to be very similar
among sisters and that there would be little individual-level
confounding by characteristics not shared among sisters up
to this age.
Methods
Generation Scotland: Scottish Family Health
Study
This study included participants in the GS:SFHS (Generation
Scotland: Scottish Family Health Study).26,27 The data,
analytical methods, and study materials will not be made
available to other researchers for the purposes of reproducing
the results or replicating the procedure. Individuals aged 35 to
65 years who were registered with collaborating general
practitioners in Glasgow and Tayside (expanded to include
Ayrshire, Arran, and northeast Scotland in 2010) were
recruited between 2006 and 2011. All volunteers provided
written informed consent and had to identify 1 ﬁrst-degree
relative aged ≥18 years who would also consent to partici-
pate. Ethics approval was obtained by the National Health
Service Tayside committee on research ethics (reference 05/
s1401/89). Data collected included self-reported information
through questionnaires as well as clinical examinations and
blood samples. The response rate was 5%, with 23 703
participants completing a preclinical questionnaire. Of the
13 946 women who completed the preclinical questionnaire,
11 639 had information on parental identiﬁcation numbers
needed to identify siblings, and 7770 had information on age
at menarche and other covariates necessary for the current
analysis (Figure 1). The study sample thus included 5984
sister groups. The number of women in each sibling group
ranged from 1 (no participating sisters for comparison) to 6 (5
participating sisters for comparison). A total of 3327 women
had at least 1 participating sister.
Age at Menarche
The questionnaire used to obtain information about female
reproductive health had 2 different versions. One version
asked the woman to give her age in whole years when she had
her ﬁrst menstrual period, and the other version asked if her
age at her ﬁrst period was <8, 8 to 9, 10 to 11, 12 to 13, 14
to 15, 16 to 17, 18 to 19, ≥20, or not known. The new
questionnaire was introduced in 2009 between July (Tayside)
and October (Glasgow). The only difference between the
groups that received the different questionnaires was the
participation date. To allow for a nonlinear relationship, we
categorized age at menarche as ≤11 years (early menarche),
12 to 13, 14 to 15, and ≥16 years (late menarche). The
reference group in all analyses comprised those with an age
at menarche of 12 to 13 years. There is some variation across
studies in the deﬁnition of early menarche (≤10, ≤11, or
≤12 years) and late menarche (≥14, ≥15, or ≥16 years), likely
inﬂuenced by the size and information available in the speciﬁc
study, but our categorization is in line with commonly used
cutoff values.4–8,10,11,14,16
Cardiometabolic Health Outcomes
Cardiometabolic health was assessed by study nurses at
recruitment. Systolic and diastolic blood pressure (mm Hg),
calculated as the average of 2 measurements; BMI (weight in
kg/height in m2); waist circumference (cm); and 12-lead ECG
were recorded (incorporated into a novel CVD risk prediction
score). Total cholesterol, high-density lipoprotein (HDL)
Clinical Perspective
What Is New?
• Associations of early menarche with cardiovascular risk
factors were explained by body mass index in adulthood.
• Adverse cardiometabolic health in women with early
menarche is not likely to be explained by shared familial
characteristics such as genetics or childhood environment.
What Are the Clinical Implications?
• Earlier age at menarche is characteristic of women with
more adverse cardiometabolic health.
• Having a healthy body mass index in adulthood could help
diminish differences in cardiometabolic health related to
age at menarche.
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cholesterol, and glucose were measured in serum using
standard clinical assays. Non-HDL cholesterol was calculated
by subtracting HDL cholesterol from total cholesterol. Overall,
85% of the blood samples procured from participants were
fasting (a minimum of 4 hours since the last meal). Further-
more, self-reported information was available regarding
diabetes mellitus in addition to the use of antihypertensive,
lipid-lowering, and antidiabetic drugs.
We calculated the 10-year risk of CVD using 2 different risk
scores. One was the Framingham 10-year risk score, which
includes age, total cholesterol, HDL cholesterol, systolic blood
pressure, smoking, and diabetes mellitus.28 The second was a
new validated 10-year risk score for CVD from the NHANES
(National Health and Nutrition Examination Survey) cohort that
uses age and a range of measurements from ECG readings,
including positive deﬂection of the T axis, negative deﬂection of
the T axis, heart rate, and corrected QT interval.29 The risk
scores were calculated only for individuals who were between
30 and 74 years of age (81% of those included in this analysis)
because the original risk scores were generated for this age
group. Individuals with self-reported history of heart disease or
stroke were excluded from the analysis of 10-year risk of CVD.
Potential Confounders
Additional self-reported information on characteristics that
could plausibly inﬂuence the associations of age at menarche
with cardiometabolic health—and confound it—included age
at recruitment (continuous), ethnicity (white versus other),
qualiﬁcations (from none to college/university degree, includ-
ing 7 categories in total), annual household income in pounds
sterling (<10 000, 10 000–30 000, 30 000–50 000,
50 000–70 000, ≥70 000, prefer not to answer), number of
pack-years of smoking (none, 1–10, 11–20, >20), number of
alcohol units consumed during the past week (none, 1–5,
6–10, >10 units), and number of hours of moderate or vigorous
physical activity during the past week (≤1 hour, 1.1–3.0, 3.1–
5.0, 5.1–10.0, 10.1–15.0, ≥15.1). Participants’ reports of
parental history of CVD (heart disease, stroke, and/or high
blood pressure) and diabetes mellitus were also considered.
Statistical Analyses
We used ﬁxed- and between-effects linear regression to
evaluate the associations of age at menarche with car-
diometabolic health. Fixed-effect linear regression provided
the within-sibships association, which is the association
between age at menarche and cardiometabolic outcomes
controlling for characteristics that are identical or very similar
among sisters, including genetics, parental socioeconomic
position, and childhood lifestyle and adiposity.30 The between-
sibships estimate was the association of age at menarche
with cardiometabolic health in unrelated women. The estimate
used data from all individuals but related the mean of the
cardiometabolic measures within a cluster (group of sisters)
to the mean age at menarche within a cluster (group of
sisters).30 If the within- and between-sibships estimates both
provide evidence of an association, this suggests that the
association between age at menarche and cardiometabolic
health is not explained by unmeasured confounding due to
genetic or environmental characteristics shared by siblings.
To test whether the between- and within-sibship estimates
were different, we used a bootstrapping test with 5000
Figure 1. Illustration of the study sample,
GS:SFHS (Generation Scotland: Scottish
Family Health Study), 2006–2011.
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iterations. We also tested for departure from linearity in the
association between age at menarche and cardiometabolic
health, using a likelihood ratio test comparing a model with
age at menarche as a categorical covariate and a model using
age at menarche as a continuum.
We incrementally adjusted for age (model 1), ethnicity,
educational qualiﬁcations, parental history of CVD, and
parental history of diabetes mellitus (model 2). The multivari-
able analysis further adjusted blood pressure for use of
antihypertensive drugs, cholesterol levels for lipid-lowering
drugs, and glucose for use of antidiabetic drugs. Potential
confounders are common causes of the exposure and outcome.
We did not have any direct measures of childhood socioeco-
nomic position in GS:SFHS and thus had to rely on adult
educational attainment as a proxy for childhood socioeconomic
position. Under the assumption that there are genes that are
common determinants of age at menarche and adverse
cardiometabolic health, which is clearly the case for obesity-
related genes,20,31 parental histories of CVD and diabetes
mellitus were also conceptualized as confounders. We then
explored further adjustment for adult lifestyle characteristics,
including pack-years of smoking, units of alcohol consumed
during the past week, and number of hours of moderate or
vigorous physical activity during the past week (model 3). These
characteristics can be conceptualized as both potential
confounders (due to tracking from childhood to adult life) and
potential mediators, given evidence of associations between
age at menarche and health-related behaviors.32
We also conducted secondary analyses adjusting the other
cardiometabolic health outcomes for adult BMI to further
explore potential direct associations. Different sensitivity
analyses included adjusting for adult household income (not
adjusted for in the primary analysis because it also reﬂects the
partner’s contribution), excluding those on medications that
could inﬂuence the outcomes of interest (for blood pressure,
cholesterol, and glucose) and excluding women who had an age
difference of >4 years with their only sibling for comparison (ie,
restricting the within-sibship analysis to sisters with an age
difference of≤4 years). This sensitivity analysiswas done under
the assumption that sisters who are closer in age aremore likely
to have a similar childhood environment. To examine the impact
of nonfasting blood sampling on the associations, we reexam-
ined the associations of age at menarche with HDL cholesterol,
non-HDL cholesterol, and glucose, excluding women with a
nonfasting blood sample (n=1132) and unknown fasting status
(n=321). We also conducted a sensitivity analysis excluding
women of non-European ethnicity (n=156).
The results presented are from a complete case analysis
because it was not possible to conduct multiple imputation
accounting for clustering, given the large number and small
size of the sibling groups. All analyses were done using Stata
version 14 (StataCorp).
Results
Women included in the analyses were younger, were more
likely to be white, had higher educational qualiﬁcations, had
lower annual household income, and were more likely to have
a family history of CVD than those excluded because of
missing covariate information (Table S1). There was no
difference in parental history of diabetes mellitus (Table S1).
Of the women included in the analysis, 18% reported
menarche at ≤11 years, whereas 52% were 12 to 13 years
at menarche, 26% were 14 to 15 years at menarche, and 4%
were ≥16 years at menarche. Age at menarche was associ-
ated with age at recruitment, qualiﬁcations, household
income, parental history of diabetes mellitus, current use of
antihypertensive medications, and, more weakly, with pack-
years of smoking, alcohol intake, and parental history of CVD
(Table). A greater proportion of the variation in age at
menarche, qualiﬁcations, and adult BMI, in addition to other
adult lifestyle characteristics, was explained by variation
within as opposed to between sibships (Table S2). Looking
more closely at the level of concordance of these traits within
sibships, there was a moderate to strong concordance for
most traits (Table S3).
Associations of Age at Menarche With
Cardiometabolic Health Outcomes
There was strong evidence of nonlinear association for most
outcomes in both the between- and within-sibship analyses
(P values <0.01), with a few exceptions. Women with early
menarche (≥11 years) had higher systolic and diastolic blood
pressure and BMI and greater waist circumference compared
with women with menarche at 12 to 13 years when examined
both within and between sibships (Figure 2). Early menarche
was also associated with lower HDL cholesterol and increased
non-HDL cholesterol both between and within sibships
(Figure 3). There was no strong evidence for differences
between the estimates from the between- and within-sibship
analyses from the bootstrapping tests (Table S4). The only
exceptions were the estimates of the associations of age at
menarche between 14 and 15 years (versus 12–13) with BMI
and waist circumference, for which the inverse association
tended to be greater when evaluated within sibships (P=0.02
and P=0.07, respectively; Table S4). Multivariable adjustment
caused only modest changes in these associations, including
adjustment for adult lifestyle characteristics (Table S4).
Associations of Age at Menarche With 10-Year
Risk of CVD
The correlation between the Framingham and NHANES 10-
year CVD risk scores was 0.83. The likelihood ratio test
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Table. Distribution of Background Characteristics by Age At Menarche, GS:SFHS, 2006–2011
Characteristics
Age At Menarche, y
≤11 (n=1395) 12–13 (n=4042) 14–15 (n=1993) ≥16 (n=340) P Value
Age at baseline evaluation, y, meanSD 44.413.6 43.613.7 45.213.8 47.012.9 <0.001
Ethnicity, n (%) 0.566
White 1365 (97.9) 3967 (98.1) 1947 (97.7) 335 (98.5)
Other 30 (2.2) 75 (1.9) 46 (2.3) 5 (1.5)
Qualifications, n (%) <0.001
College/university degree 422 (30.3) 1451 (35.9) 680 (34.1) 98 (28.8)
Other professional or technical qualification 300 (21.5) 789 (19.5) 394 (19.8) 76 (22.4)
NVQ/HND/HNC or equivalent 131 (9.4) 345 (8.5) 154 (7.7) 31 (9.1)
Higher grade 177 (12.7) 516 (12.8) 244 (12.2) 24 (7.1)
Standard grade/O level/GCSE 184 (13.2) 486 (12.0) 248 (12.4) 49 (14.4)
CSEs, school leavers certificate,
other or no qualifications
181 (13.0) 455 (11.3) 273 (13.7) 62 (18.2)
Annual household income, £, n (%) 0.005
<10 000 114 (8.2) 259 (6.4) 112 (5.6) 32 (9.4)
10 000–30 000 414 (29.7) 1081 (26.7) 546 (27.4) 100 (29.4)
30 000–50 000 335 (24.0) 1021 (25.3) 507 (25.4) 77 (22.7)
50 000–70 000 172 (12.3) 579 (14.3) 306 (15.4) 37 (10.9)
≥70 000 132 (9.5) 453 (11.2) 183 (9.2) 32 (9.4)
Prefer not to answer 72 (5.2) 201 (5.0) 109 (5.5) 26 (7.7)
Missing 156 (11.1) 448 (11.1) 230 (11.5) 36 (10.6)
Pack-years of smoking, n (%) 0.084
None 836 (59.9) 2566 (63.5) 1223 (61.4) 208 (61.2)
1–10 247 (17.7) 703 (17.4) 366 (18.4) 57 (16.8)
11–20 106 (7.6) 286 (7.1) 128 (6.4) 20 (5.9)
≥20 206 (14.8) 487 (12.1) 276 (13.9) 55 (16.2)
Number of alcohol units consumed
during the past week, n (%)
0.083
None 330 (23.7) 813 (20.1) 425 (21.3) 64 (18.8)
1–5 349 (25.0) 1001 (24.8) 457 (22.9) 93 (27.4)
6–10 326 (23.4) 1039 (25.7) 486 (24.4) 79 (23.2)
≥10 288 (20.7) 918 (22.7) 483 (24.2) 77 (22.7)
Missing 102 (7.3) 271 (6.7) 142 (7.1) 27 (7.9)
Number of hours of moderate or vigorous
physical activity during the past week, n (%)
0.509
≤1 162 (11.6) 534 (13.2) 232 (11.6) 38 (11.2)
1.1–3.0 296 (21.2) 875 (21.7) 415 (20.8) 65 (19.1)
3.1–5.0 151 (10.8) 463 (11.5) 223 (11.2) 42 (12.4)
5.1–10.0 300 (21.5) 734 (18.2) 383 (19.2) 69 (20.3)
10.1–15.0 148 (10.6) 422 (10.4) 201 (10.1) 41 (12.1)
≥15.1 225 (16.1) 689 (17.1) 360 (18.1) 55 (16.2)
Missing 113 (8.1) 325 (8.0) 179 (9.0) 30 (8.8)
Parental history of CVD, n (%) 0.088
Continued
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comparing models including age at menarche as a categorical
versus a continuous variable supported the presence of a
nonlinear association between age at menarche and 10-year
risk of CVD (P<0.01). Early menarche was associated with
higher 10-year CVD risk using both scores compared with age
at menarche of 12 to 13 years, which was consistent for both
within- and between-sibship estimates (Figure 4). Using the
Framingham risk score, but not NHANES, age at menarche of
≥16 years was also associated with higher 10-year CVD risk in
models 1 and 2 but not in model 3 (which controlled for adult
characteristics; Table S5).
Sensitivity Analyses
Additional multivariable adjustment for adult household
income did not change the associations (results available on
request). Excluding those using antihypertensive medications
from the analysis of blood pressure, those on lipid-lowering
medications from the analysis of cholesterol, and those on
antidiabetic medications from the analysis of glucose yielded
similar associations but wider conﬁdence intervals (Table S6).
When we adjusted the associations of age at menarche with
other cardiometabolic outcomes for adult BMIs, all associa-
tions were attenuated and the conﬁdence intervals included
the null value (Tables S7 and S8). Restricting the within-
sibship analysis to sisters with an age difference of ≤4 years
yielded associations of slightly greater magnitude (Tables S9
and S10). The sensitivity analysis excluding women of non-
European ethnicity yielded ﬁndings similar to the main
analysis (Tables S11 and S12). Finally, excluding women with
a nonfasting blood sample did not change the observed
associations of age at menarche with HDL or non-HDL
cholesterol (Table S13). For glucose, the association with age
at menarche of ≤11 years within sibships was of a slightly
greater magnitude, whereas the association with menarche
after 14 years within sibships was attenuated (Table S13).
However, these changes in the associations did not change
the overall conclusion.
Discussion
In this sibship study, women who experienced early menarche
(≤11 years) had a more adverse cardiometabolic proﬁle and
an increased 10-year CVD risk score compared with women
who experienced menarche at 12 to 13 years. The results
were similar in unrelated women and within sister groups.
Later menarche (14–15 and ≥16 years) was associated with
lower BMI and waist circumference (both within and between
sister groups) but not with other cardiometabolic health
outcomes or the 10-year risk of CVD.
These results suggest that associations found in this study
and elsewhere1–8,10,12,13,15 between early menarche and CVD
risk factors and events are not explained by genetic or other
characteristics shared by sisters. This interpretation requires a
Table. Continued
Characteristics
Age At Menarche, y
≤11 (n=1395) 12–13 (n=4042) 14–15 (n=1993) ≥16 (n=340) P Value
No 461 (33.1) 1476 (36.5) 700 (35.1) 112 (32.9)
Yes 934 (67.0) 2566 (63.5) 1293 (64.9) 228 (67.1)
Parental history of diabetes mellitus, n (%) 0.037
No 1146 (82.2) 3423 (84.7) 1708 (85.7) 291 (85.6)
Yes 249 (17.9) 619 (15.3) 285 (14.3) 49 (14.4)
Use of antihypertensive medications, n (%) 0.002
No 1251 (89.7) 3733 (92.4) 1857 (93.2) 314 (92.4)
Yes 144 (10.3) 309 (7.6) 136 (6.8) 26 (7.7)
Use of lipid-lowering medications, n (%) 0.376
No 1318 (94.5) 3863 (95.6) 1894 (95.0) 322 (94.7)
Yes 77 (5.5) 179 (4.4) 99 (5.0) 18 (5.3)
Use of antidiabetic medications, n (%) 0.745
No 1380 (98.9) 4004 (99.1) 1978 (99.3) 336 (98.8)
Yes 15 (1.1) 38 (0.9) 15 (0.8) 4 (1.2)
CSE indicates certiﬁcate of secondary education; CVD, cardiovascular disease; GCSE, general certiﬁcate of secondary educations; GS:SFHS, Generation Scotland: Scottish Family Health
Study; HNC, higher national certiﬁcate; HND, higher national diploma; and NVQ,national vocational qualiﬁcations.
DOI: 10.1161/JAHA.117.007780 Journal of the American Heart Association 6
Age at Menarche and Cardiometabolic Health Magnus et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on M
arch 13, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
strong assumption: that there is little individual-level confound-
ing. If siblings differ to a greater extent with regard to
distributions of potential confounders than to the exposure of
interest, the within-sibships analysismay bemore biased than a
standard analysis.21,33 Consequently, a key underlying assump-
tion is that childhood adiposity (a key potential confounder in
this study), and other lifestyle characteristics, are more similar
within sisters than between unrelated individuals, and that the
concordance for these potential confounders is greater than
the concordance for age at menarche. The GS:SFHS does not
have any information on childhood environmental characteris-
tics; therefore, we cannot directly test this assumption. We did
ﬁnd moderate to strong concordance within sibling groups for
adult socioeconomic position and lifestyle characteristics,
which indicates that the main confounders for this analysis are
likely strongly correlated within siblings, since childhood
lifestyle is assumed to be even more concordant within siblings
than adult lifestyle. When we repeated the within-sibships
analyses among sisters with an age difference of up to 4 years,
results were similar to the main analysis. Even though we found
insufﬁcient evidence to state that the estimates from the
within- and between-sibship analyses differed, this might be
inﬂuenced by the sample size, and we cannot exclude the
possibility that a larger sample could provide more conclusive
evidence for, or against, an unconfounded causal effect of age
at menarche with adverse cardiometabolic risk.
Siblings are widely assumed to experience a similar
environment during early childhood, but we might speculate
that they start to increasingly diverge around school age.
However, evidence shows that physical activity has a strong
A B
C D
Figure 2. Adjusted associations of age at menarche with blood pressure and adiposity, GS:SFHS (Generation Scotland: Scottish Family Health
Study), 2006–2011. The comparison group comprises women with an age at menarche of 12 or 13 years. A, Systolic blood pressure (mm Hg).
B, Diastolic blood pressure (mm Hg). C, Body mass index. D, Waist circumference (cm). Adjusted for age, ethnicity, qualiﬁcations, parental
history of cardiovascular disease, and parental history of diabetes mellitus. Blood pressure was further adjusted for use of antihypertensive
drugs. CI indicates conﬁdence interval.
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heritable component during adolescence34,35 and that family-
level characteristics play a more important role in determining
children’s sedentary time compared with school-level
characteristics.36 There is also a strong correlation in
childhood adiposity among siblings, and having an obese
elder sibling is associated with a 5-fold increase in obesity in
the younger sibling; the similarity is even greater among
siblings of the same sex.37,38
Our results could be inﬂuenced by selection bias due to the
low participation rate in the GS:SFHS; however, the mean age
at menarche in the cohort (13.1 years) is fairly similar to the
average reported for women born between 1950 and 1980
from the Breakthrough Generations Study (12.7 years).39
Notably, we had information on age at menarche only in years
and not months in GS:SFHS, and this could have resulted in a
slight overestimation of the mean. It is also important to keep
in mind that the low participation rate also reﬂects the unique
sampling strategy of the cohort because participants were
required to identify a family member who was also willing to
participate. We cannot exclude the possibility that
A B C
Figure 3. Adjusted associations of age at menarche with cholesterol and glucose, GS:SFHS (Generation Scotland: Scottish Family Health
Study), 2006–2011. The comparison group comprises women with an age at menarche of 12 or 13 years. A, HDL cholesterol (mmol/L). B,
Non-HDL cholesterol (mmol/L). C, Glucose (mmol/L). Adjusted for age, ethnicity, qualiﬁcations, parental history of cardiovascular disease, and
parental history of diabetes mellitus. Cholesterol levels further adjusted for lipid-lowering drugs and glucose adjusted for use of antidiabetic
drugs. CI indicates conﬁdence interval; HDL, high-density lipoprotein.
A B
Figure 4. Adjusted association between age at menarche and 10-year risk score of overall cardiovascular disease, GS:SFHS (Generation
Scotland: Scottish Family Health Study), 2006–2011. The comparison group comprises women with an age at menarche of 12 or 13 years. A,
Framingham risk score. B, NHANES (National Health and Nutrition Examination Survey) ECG risk score. The variables included in the
Framingham risk score are age, total cholesterol, HDL cholesterol, systolic blood pressure, smoking, and diabetes mellitus. The information
included in the NHANES ECG risk score included age, positive deﬂection of the T axis, negative deﬂection of the T axis, heart rate, and corrected
QT interval. The associations are adjusted for age, ethnicity, qualiﬁcations, parental history of cardiovascular disease, and parental history of
diabetes mellitus. CI indicates conﬁdence interval.
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participation could be inﬂuenced by background characteris-
tics associated with both the exposure and the outcome, such
as childhood socioeconomic position and/or lifestyle charac-
teristics. For example, the proportion of women who had a
university degree in our analysis sample was greater than the
national average identiﬁed in the 2011 Scottish census (34%
versus 25%).40 This might have resulted in underestimation of
the associations of interest.
We relied on self-report of age at menarche a long time
after the event occurred (median: 32 years; range: 5.5–59
years). This should not have resulted in substantial
misclassiﬁcation because previous studies have shown
good validity of retrospectively recalled age at menarche.34
However, any misclassiﬁcation in the exposure tends to
exaggerate effects in within-sibling analyses.33 Conse-
quently, if there were substantial misclassiﬁcation of age
at menarche, it would have caused overestimation of the
association with cardiometabolic health within sister groups,
and contributed to the weak evidence of a difference in the
associations within sister groups and between unrelated
individuals. This possibility cannot be excluded. Finally, our
study had limited power to evaluate associations with late
menarche, given the relatively modest size of this group in
the cohort.
Whether childhood adiposity is the sole driver of the
associations of age at menarche with cardiometabolic health
and CVD events, related to its strong inverse relationship with
age at menarche,41,42 remains to be determined. A limited
number of studies were able to adjust for childhood
characteristics when studying the associations of age at
menarche with cardiometabolic health.2,4,14 Two studies that
had data on BMI before menarche indicated that adjustment
for childhood BMI virtually completely attenuated the asso-
ciation between age at menarche and adult BMI.4,14 In this
study and elsewhere, the associations of age at menarche
with cardiometabolic outcomes were attenuated after adjust-
ment for adult BMI.4 However, because BMI tracks across the
life course, it is difﬁcult to truly distinguish confounding
(childhood BMI) from mediation (adult BMI) of the associa-
tions of age at menarche with other cardiometabolic health
outcomes.
Greater conﬁdence in causal inference from observational
studies stems from consistent evidence across different
studies and the use of different analytical approaches to
address confounding and selection bias.23 The sibling com-
parison used in the current study is one such study-design,
but it is important to note that if its assumptions are violated,
it may result in greater bias than conventional multivariable
adjustment. Another increasingly popular approach is Men-
delian randomization, which addresses unmeasured and
residual confounding by using genetic polymorphisms as
instrumental variables for the exposure of interest, based on
their random allocation at conception resulting in their
independence of confounding factors.43 However, the poten-
tial to use Mendelian randomization to study age at menarche
in relation to cardiometabolic health is hampered by the
number of overlapping genes associated with both age at
menarche and adiposity.20,31 Longitudinal studies with mea-
sures of adiposity before and after puberty have the potential
to contribute valuable insight into the role of childhood
adiposity in the associations of age at menarche with
cardiometabolic health, with studies that have been able to
do this suggesting that childhood BMI before puberty
confounds any associations with adult BMI4,14 and thus,
potentially, with cardiometabolic risk.
In conclusion, early menarche is associated with an
overall adverse cardiometabolic proﬁle and a higher 10-year
risk score for CVD. The associations were similar when
evaluated within sisters and between unrelated individuals,
suggesting that confounding by shared familiar character-
istics is unlikely to be a major driver of the association;
but, this does not exclude counfounding by individual-level
characteristics.
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Table S1. Background Characteristics Among Individuals Included and Excluded from 
Analyses Due to Missing Data, the Scottish Family Health Study, 2006-2011. 
 
Characteristics Excluded 
(n= 6,176) 
Included 
(n=7,770) 
P-value 
n/mean %/SD n/mean %/SD  
Age at baseline evaluation  52.1 16.1 44.3 13.7 <0.001 
Ethnicity      <0.001 
    White 5,691 95.9 7,614 98.0  
    Other 246  4.1 156  2.0  
    Missing 239   0    
Qualifications      <0.001 
     College/University degree 1,594 31.0 2,651  34.1  
     Other professional or technical qualification 826  16.1 1,559 20.1  
     NVQ/HND/HNC or equivalent 472  9.2 661  8.5  
     Higher Grade 465  9.1 961  12.4  
     Standard Grade/O Level/GCSE 590  11.5 967  12.5  
     CSEs, School leavers certificate, other or no qualifications 1,193   23.2 971  12.5  
     Missing 1,036  0    
Annual household income, pounds      <0.001 
     <10,000 509  10.4 517  7.5  
      10,000-30,000 1,591 32.4 2,141  31.0  
      30,000-50,000 1,151  23.5 1,940  28.1  
      50,000-70,000 627  12.8 1,094  15.9  
      70,000+ 510  10.4 800  11.6  
      Prefer not to answer 516  10.5 408  5.9  
      Missing 1,272  870   
Parental history of CVD      <0.001 
     No 1,260  32.0 2,749  35.4  
     Yes 2,673  68.0 5,021  64.6  
    Missing 2,243  0   
Parental history of diabetes      0.143 
     No 3,365  85.6 6,568  84.5  
    Yes 568  14.4 1,202  15.5  
    Missing 2,243  0   
CVD=cardiovascular disease. 
 
Percentages and test of differences in distributions among those with and without the 
necessary follow-up information are based on observed values and missing categories are not 
included. 
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Table S2. Proportion of the Variation in Traits Explained by Variation Between and Within 
Sibships/Groups of Sisters, the Scottish Family Health Study, 2006-2011. 
  
Characteristics Proportion 
explained by 
variation between 
sibships 
Proportion 
explained by 
variation 
within sibships 
Age (years)   
Age at menarche (years) 0.27 0.73 
Qualifications (ordered from CSE/school leavers to 
college/university degree) 
0.40 0.60 
Current smoking at recruitment (yes versus no) 0.37 0.63 
Hours of moderate/vigorous physical activity in the past week 0.48 0.52 
Units of alcohol consumed in the past week 0.07 0.93 
Adult BMI 0.31 0.69 
 
BMI=body-mass index. 
The proportion of variation explained by variation between sibships/groups of sisters 
estimated using the intra-class correlation coefficient from a random effects linear/logistic 
regression model.  
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Table S3. Pairwise Discordance in Traits Between Sibships, the Scottish Family Health 
Study, 2006-2011. 
 
  
Characteristics Number of pairs  % 
Difference in age (years) 
Number of sibling groups=1,541 (Number of women=3,327) 
  
0-2 584  37.9 
3-4 464  30.1 
5-6 219  14.2 
More than 6 274  17.8 
Difference in age at menarche (years) 
Number of sibling groups=1,541 (Number of women=3,327) 
  
0 582  37.8 
1 331  21.5 
2 440  28.6 
3 93  6.0 
More than 3.0 95  6.2 
Discordance in college/university degree  
Number of sibling groups=1,541(Number of women=3,327) 
  
No  1,139 73.9 
Yes 402  26.1 
Discordance in current smoking at recruitment 
Number of groups= 1,520 (Number of women= 3,280) 
  
No  1,235  81.3 
Yes 285  18.7 
Difference in hours of moderate/vigorous physical activity in the 
past week 
Number of sibling groups= 1,332 (Number of women= 2,863) 
  
0-2.9 524  39.3 
3.0-5.9 310  23.2 
6.0 or more 498 37.4 
Difference in units of alcohol consumed in the past week 
Number of sibling groups= 1,378 (Number of women= 2,961) 
  
0-1 304  22.1 
2-3 297  21.6 
4-5 204  14.8 
6 or more 573  41.6 
Difference in adult body-mass index 
Number of sibling groups= 1,513 (Number of women= 3,265) 
  
0-2 582  38.5 
3-4 318  21.0 
5-6 233  15.4 
More than 6 380  25.1 
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Table S4. Association Between Age at Menarche and Cardiometabolic Health Outcomes, the Scottish Family Health Study, 2006-2011. 
 
Outcome Model Age at menarche N Mean/Median  SD/Range Within-sibships 
association 
Between-sibships 
association 
Bootstrap p-value for the 
difference in the within and 
between sibship association 
β 95% CI β 95% CI  
Systolic blood 
pressure (mmHg) 
Model 1 11 or younger  1,392 127.5  17.2 1.97  -0.16, 4.10 2.08 1.06, 3.10 0.99 
12-13 4,034 124.9  16.5 Ref  Ref  NA 
14-15 1,989 125.6  17.6 -0.02 -1.67, 1.62 -0.47 -1.37, 0.44 0.67 
16 or higher 339 126.6  18.0 -2.50 -5.98, 0.97 0.76  -1.18, 2.69 0.33 
Model 2 11 or younger  1,392 127.5  17.2 1.73  -0.41, 3.86 1.71  0.71, 2.72 0.94 
12-13 4,034 124.9  16.5 Ref  Ref  NA 
14-15 1,989 125.6  17.6 -0.01 -1.66, 1.64 -0.38  -1.28, 0.51 0.74 
16 or higher 339 126.6  18.0 -2.62 -6.10, 0.86 0.81  -1.10, 2.73 0.31 
Model 3 11 or younger  1,189 127.3  17.2 2.26  -0.26, 4.78 1.74  0.68, 2.80 0.78 
12-13 3,474 124.7  16.3 Ref  Ref  NA 
14-15 1,687 125.1  17.3 0.44  -1.45, 2.32 -0.41  -1.35, 0.53 0.54 
16 or higher 285 126.1  17.4 -2.74 -6.52, 1.04 0.31  -1.69, 2.32 0.34 
Diastolic blood 
pressure (mmHg) 
Model 1 11 or younger  1,392 79.2  10.1 1.39  0.11, 2.67 1.48  0.83, 2.12 0.98 
12-13 4,034 77.5  9.9 Ref  Ref  NA 
14-15 1,989 77.1  10.0 -0.62 -1.64, 0.41 -0.86  -1.44, -0.28 0.70 
16 or higher 339  77.8  10.1 -0.38 -2.49, 1.73 -0.38  -1.62, 0.85 0.86 
Model 2 11 or younger  1,392 79.2  10.1 1.26  -0.02, 2.55 1.32  0.68, 1.96 0.99 
12-13 4,034 77.5  9.9 Ref  Ref  NA 
14-15 1,989 77.1  10.0 -0.62 -1.64, 0.40 -0.83  -1.40, -0.25 0.75 
16 or higher 339  77.8  10.1 -0.45 -2.57, 1.67 -0.36  -1.58, 0.87 0.89 
Model 3 11 or younger  1,189 79.2  10.1 1.74  0.22, 3.25 1.39  0.71, 2.08 0.75 
12-13 3,474 77.4  9.8 Ref  Ref  NA 
14-15 1,687 77.0  10.1 -0.37 -1.52, 0.78 -0.66  -1.27, -0.05 0.67 
16 or higher 285 77.8  10.3 -0.93 -3.40, 1.54 -0.06  -1.36, 1.24 0.74 
HDL cholesterol, 
(mmol/L) 
Model 1 11 or younger  1,338 1.537  0.404 -0.064  -0.109, -0.019 -0.045  -0.074, -0.017 0.65 
12-13 3,851 1.591  0.418 Ref  Ref  NA 
14-15 1,897 1.627  0.405 -0.009 -0.050, 0.033 0.040  0.014, 0.065 0.13 
16 or higher 
 
 
326 1.646  0.432 -0.025 -0.109, 0.060 0.058  0.004, 0.113 0.21 
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Model 2 11 or younger  1,338 1.537  0.404 -0.060 -0.105, -0.015 -0.038 -0.066, -0.010 0.54 
12-13 3,851 1.591  0.418 Ref  Ref  NA 
14-15 1,897 1.627  0.405 -0.010 -0.052, 0.032 0.041  0.016, 0.066 0.11 
16 or higher 326 1.646  0.432 -0.024  -0.108, 0.060 0.066  0.012, 0.120 0.18 
Model 3 11 or younger  1,146 1.547  0.405 -0.042 -0.093, 0.008 -0.038  -0.067, -0.009 0.96 
12-13 3,315 1.604  0.415 Ref  Ref  NA 
14-15 1,615 1.639  0.408 -0.009  -0.057, 0.039 0.037  0.011, 0.063 0.22 
16 or higher 276 1.674  0.437 -0.017  -0.105, 0.071 0.061  0.005, 0.116 0.24 
Non-HDL 
cholesterol 
(mmol/L) 
Model 1 11 or younger  1,338 3.638  1.065 0.196  0.073, 0.319 0.063  -0.004, 0.131 0.20 
12-13 3,851 3.517  1.050 Ref  Ref  NA 
14-15 1,897 3.498  1.031 0.021  -0.087, 0.129 -0.100  -0.160, -0.040 0.13 
16 or higher 326 3.583  1.008 -0.035 -0.235, 0.166 -0.030  -0.158, 0.099 0.97 
Model 2 11 or younger  1,338 3.638  1.065 0.202  0.084, 0.321 0.051  -0.015, 0.117 0.13 
12-13 3,851 3.517  1.050 Ref  Ref  NA 
14-15 1,897 3.498  1.031 0.012  -0.092, 0.115 -0.106  -0.165, -0.047 0.14 
16 or higher 326 3.583  1.008 -0.032 -0.217, 0.153 -0.048  -0.174, 0.077 0.88 
Model 3 11 or younger  1,146 3.629 1.068 0.142  0.009, 0.274 0.068  -0.002, 0.137 0.49 
12-13 3,315 3.491 1.039 Ref  Ref  NA 
14-15 1,615 3.462 1.021 -0.013 -0.132, 0.105 -0.092  -0.154, -0.030 0.37 
16 or higher 276 3.539 1.001 0.071  -0.281, 0.139 -0.070 -0.201, 0.061 0.96 
Glucose, 
(mmol/L)* 
 
 
Model 1 11 or younger  1,317 4.6 4.3, 4.9 -0.732 -2.418, 0.954 1.349  0.456, 2.241 0.11 
12-13 3,814 4.5 4.3, 4.8 Ref  Ref  NA 
14-15 1,876 4.6 4.3, 4.8 0.879  -0.504, 2.262 -0.386  -1.185, 0.413 0.29 
16 or higher 327 4.6  4.3, 4.8 -0.761 -3.803, 2.281 -0.853  -2.553, 0.846 0.91 
Model 2 11 or younger  1,317 4.6  4.3, 4.9 -0.338 -1.975, 1.298 1.143  0.287, 1.999 0.23 
12-13 3,814 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,876 4.6  4.3, 4.8 0.983  -0.352, 2.318 -0.266  -1.032, 0.499 0.27 
16 or higher 327 4.6  4.3, 4.8 -0.849 -3.941, 2.243 -0.892  -2.521, 0.737) 0.89 
Model 3 11 or younger  1,126 4.6  4.3, 4.9 -0.022 -2.002, 1.958 1.006  0.125, 1.888 0.43 
12-13 3,282 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,599 4.6  4.3, 4.8 1.534  0.021, 3.047 -0.212  -0.999, 0.576 0.17 
16 or higher 276 4.6  4.3, 4.8 -2.585 -6.208, 1.038 -0.721  -2.396, 0.953 0.54 
Body-mass index 
(kg/m2)  
Model 1 11 or younger  1,374 28.081  6.170 1.687  0.997, 2.377 1.871  1.509, 2.232 0.64 
12-13 3,997 26.107  5.195 Ref  Ref  NA 
14-15 1,975 25.048  4.771 -0.477 -0.976, 0.022 -1.343  -1.664, -1.021 0.02 
16 or higher 
 
334 25.424  5.398 -0.650 -1.693, 0.392 -1.060  -1.749, -0.371 0.73 
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Model 2 11 or younger  1,374 28.081  6.170 1.598  0.919, 2.278 1.742  1.386, 2.098 0.70 
12-13 3,997 26.107  5.195 Ref  Ref  NA 
14-15 1,975 25.048  4.771 -0.478 -0.981, 0.024 -1.338 -1.655, -1.022 0.03 
16 or higher 334 25.424  5.398 -0.670 -1.705, 0.366 -1.187  -1.865, -0.509 0.65 
Model 3 11 or younger  1,146 3.629  1.068 1.691  0.942, 2.440 1.663  1.295, 2.031 0.94 
12-13 3,315 3.491  1.039 Ref  Ref  NA 
14-15 1,615 3.462  1.021 -0.620 -1.172, -0.068 -1.249  -1.576, -0.921 0.16 
16 or higher 276 3.539  1.001 -1.411 -2.511, -0.311 -0.959  -1.658, -0.260 0.56 
Waist 
circumference, 
(cm) 
Model 1 11 or younger  1,364 88.20  15.30 2.907  1.200, 4.614 3.530  2.590, 4.472 0.55 
12-13 3,981 84.48  13.80 Ref  Ref  NA 
14-15 1,966 82.53  12.71 -0.847 -2.240, 0.546 -2.723  -3.560, -1.887 0.07 
16 or higher 335 83.66  14.49 -1.903 -4.576, 0.770 -1.665  -3.455, 0.124 0.83 
Model 2 11 or younger  1,364 88.20  15.30 2.752  1.060, 4.444 3.172  2.246, 4.099 0.67 
12-13 3,981 84.48 13.80 Ref  Ref  NA 
14-15 1,966 82.53 12.71 -0.868 -2.263, 0.528 -2.755  -3.578, -1.932 0.07 
16 or higher 335 83.66 14.49 -1.902 -4.569, 0.765 -2.056  -3.817, -0.294 0.98 
Model 3 11 or younger  1,166 87.64 14.97 2.598  0.809, 4.387 3.068  2.108, 4.027 0.72 
12-13 3,437 84.05 13.46 Ref  Ref  NA 
14-15 1,672  81.95 12.19 -1.235 -2.710, 0.239 -2.642  -3.496, -1.789 0.20 
16 or higher 282 83.02  13.90 -3.069 -5.657, -0.481 -1.686  -3.510, 0.137 0.49 
 
CI=confidence interval; HDL=high-density lipoprotein; SD=standard deviation. 
 
Model 1 Adjusted for age 
Model 2 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease and parental history of diabetes. Blood pressure further adjusted for use of antihypertensive drugs, 
cholesterol levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs. 
Model 3 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease, parental history of diabetes, smoking, alcohol intake and leisure time physical activity. Blood 
pressure further adjusted for use of antihypertensive drugs, cholesterol levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs. 
 
*Outcome log transformed and the coefficients reflect the percent change in the outcome.  
 
  
 by guest on M
arch 13, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Table S5. Association Between Age at Menarche and 10-Year Risk For Overall Cardiovascular Disease, the Scottish Family Health Study, 2006-2011.   
Risk score Model Age at menarche N Mean SD Within-sibships association  Between-sibships association Bootstrap p-value for the 
difference in the within and 
between sibship association 
β  95% CI β  95% CI  
Framingham 
risk score * 
Model 1 11 or younger  1,076 26.06 0.91 0.09  0.02, 0.17 0.10  0.06, 0.14 0.80 
12-13 3,014 25.94 0.90 Ref  Ref  NA 
14-15 1,543 25.97 0.92 0.02  -0.04, 0.08 -0.03 -0.07, 0.00 0.24 
16 or higher 272 26.07 0.87 -0.03  -0.15, 0.09 0.04  -0.04, 0.12 0.54 
Model 2 11 or younger  1,076 26.06  0.91 0.08  0.00, 0.16 0.09  0.05, 0.13 0.85 
12-13 3,014 25.94  0.90 Ref  Ref  NA 
14-15 1,543 25.97  0.92 0.02  -0.04, 0.08 -0.04  -0.07, 0.00 0.20 
16 or higher 272 26.07  0.87 -0.03 -0.15, 0.09  0.02  -0.05, 0.09 0.68 
Model 3 11 or younger  922 26.04  0.90 0.08  -0.01, 0.17 0.08  0.04, 0.13 0.85 
12-13 2,591 25.92  0.89 Ref  Ref  NA 
14-15 1,312 25.94  0.91 0.02  -0.05, 0.09 -0.02 -0.06, 0.01 0.40 
16 or higher 231 26.01  0.84 -0.04  -0.18, 0.10 0.01  -0.07, 0.08) 0.71 
NHANES 
ECG risk 
equation 
score † 
Model 1 11 or younger  1,076 7.963  0.847 0.030  -0.004, 0.064 0.018  0.001, 0.035 0.62 
12-13 3,054 7.928  0.845 Ref  Ref  NA 
14-15 1,581 7.970  0.880 0.002  -0.025, 0.030 -0.020  -0.035, -0.005 0.27 
16 or higher 265 8.061  0.819 0.003  -0.056, 0.063 0.027  -0.005, 0.059 0.82 
Model 2 11 or younger  1,076 7.963  0.847 0.031  -0.003, 0.065 0.015  -0.002, 0.032 0.52 
12-13 3,054 7.928  0.845 Ref  Ref  NA 
14-15 1,581 7.970  0.880 0.004  -0.024, 0.031 -0.020  -0.035, -0.005 0.24 
16 or higher 265 8.061  0.819 0.003  -0.057, 0.064 0.025  -0.007, 0.057 0.85 
Model 3 11 or younger  919 7.957  0.846 0.044  0.005, 0.083 0.023  0.006, 0.041 0.43 
12-13 2,625 7.914  0.845 Ref  Ref  NA 
14-15 1,336 7.928  0.865 -0.015  -0.047, 0.017 -0.014 -0.030, 0.001 0.93 
16 or higher 224 8.025  0.783 -0.001  -0.073, 0.071 0.027  -0.005, 0.060 0.79 
CI=confidence interval; ECG=electrocardiogram; SD=standard deviation. 
* The variables included in the Framingham risk score is age, total cholesterol, HDL cholesterol, systolic blood pressure, smoking and diabetes.  
† The information included in the NHANES ECG risk score included age, positive deflection of T axis, negative deflection of the T axis, heart rate and corrected QT interval.   
Model 1 Adjusted for age 
Model 2 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease and parental history of diabetes.  
Model 3 Adjusted for all of the covariates in Model 2 in addition to smoking (not adjusted for in the analysis of the Framingham risk score since part of the risk calculation), alcohol intake and 
leisure time physical activity. 
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Table S6. Associations of Age at menarche With Blood pressure, Cholesterol and Glucose Excluding Individuals On Medications That Might Influence the 
Outcomes, the Scottish Family Health Study, 2006-2011. 
Outcome Model Age at 
menarche 
N Mean/Median  
 
SD/Range Within-sibships 
association 
Between-sibships association Bootstrap p-value for 
the difference in the 
within and between 
sibship association 
β  95% CI β  95% CI  
Systolic 
blood 
pressure 
(mmHg) 
Model 1 11 or younger  1,249 126.34  16.66 1.81  -0.40, 4.02 2.21  1.19, 3.24 0.80 
12-13 3,728 123.79  15.72 Ref  Ref  NA 
14-15 1,853 124.56  16.80 -0.07  -1.79, 1.65 -0.26  -1.17, 0.64 0.81 
16 or higher 313 125.04  16.20 -2.69  -6.23, 0.85 0.03  -1.89, 1.96 0.39 
Model 2 11 or younger  1,249 126.34  16.66 1.55  -0.67, 3.77 2.00  0.98, 3.01 0.79 
12-13 3,728 123.79  15.72 Ref  Ref  NA 
14-15 1,853 124.56  16.80 -0.08  -1.79, 1.63 -0.28  -1.18, 0.62 0.83 
16 or higher 313 125.04  16.20 -2.84  -6.39, 0.70 -0.18  -2.09, 1.74 0.40 
Model 3 11 or younger  1,076 126.27  16.75 2.12  -0.53, 4.77 2.05  0.98, 3.13 0.97 
12-13 3,221 123.63  15.55 Ref  Ref  NA 
14-15 1,580 124.13  16.55 0.50  -1.44, 2.44 -0.30  -1.25, 0.65 0.56 
16 or higher 268 124.74  15.83 -2.46  -6.15, 1.23 -0.46  -2.47, 1.56 0.54 
Diastolic 
blood 
pressure 
(mmHg) 
Model 1 11 or younger  1,249 78.76  9.99 1.29  -0.10, 2.67 1.43  0.77, 2.09 0.88 
12-13 3,728 77.12  9.68 Ref  Ref  NA 
14-15 1,853 76.82  10.0 -0.49  -1.57, 0.60 -0.79  -1.38, -0.21 0.67 
16 or higher 313 77.60  9.86 -0.08  -2.37, 2.21 -0.39  -1.64, 0.85 0.79 
Model 2 11 or younger  1,249 78.76  9.99 1.14  -0.25, 2.53 1.30  0.65, 1.96 0.86 
12-13 3,728 77.12  9.68 Ref  Ref  NA 
14-15 1,853 76.82  10.0 -0.49  -1.57, 0.59 -0.78  -1.36, -0.20 0.70 
16 or higher 313 77.60  9.86 -0.19  -2.49, 2.11 -0.43  -1.66, 0.81 0.81 
Model 3 11 or younger  1,076 78.71  10.02 1.51  -0.13, 3.15 1.34 0.64, 2.04 0.92 
12-13 3,221 76.99  9.65 Ref  Ref  NA 
14-15 1,580 76.72  10.05 -0.20  -1.41, 1.00 -0.64  -1.26, -0.01 0.57 
16 or higher 268 77.65  10.03 -0.24  -2.81, 2.33 -0.11  -1.42, 1.20 0.98 
HDL 
cholesterol, 
(mmol/L) 
Model 1 11 or younger  1,266 1.540  0.408 -0.056  -0.102, -0.010 -0.050 -0.079, -0.021 0.93 
12-13 3,675 1.595  0.415 Ref  Ref  NA 
14-15 1,806 1.626  0.404 -0.013  -0.056, 0.030 0.032  0.006, 0.058 0.18 
16 or higher 308 1.658  0.436 -0.023  -0.116, 0.070 0.055  0.000, 0.110 0.25 
Model 2 11 or younger  1,266 1.540  0.408 -0.054  -0.100, -0.008 -0.042  -0.071, -0.013 0.78 
12-13 3,675 1.595  0.415 Ref  Ref  NA 
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14-15 1,806 1.626  0.404 -0.014  -0.057, 0.030 0.034  0.008, 0.060 0.16 
16 or higher 308 1.658  0.436 -0.022  -0.115, 0.071 0.064  0.009, 0.118 0.21 
Model 3 11 or younger  1,101 1.551  0.410 -0.034  -0.087, 0.017 -0.044  -0.074, -0.014 0.77 
12-13 3,173 1.608  0.412 Ref  Ref  NA 
14-15 1,546 1.638  0.408 -0.009  -0.058, 0.040 0.029  0.003, 0.056 0.32 
16 or higher 265 1.679  0.442 -0.009  -0.103, 0.084 0.054  -0.002, 0.111 0.33 
Non-HDL 
cholesterol 
(mmol/L) 
Model 1 11 or younger  1,266 3.657  1.070 0.210  0.087, 0.334 0.062  -0.006, 0.129 0.17 
12-13 3,675 3.530  1.050 Ref  Ref  NA 
14-15 1,806 3.514  1.032 -0.013  -0.122, 0.095 -0.097  -0.157, -0.037 0.31 
16 or higher 308 3.574  1.001 -0.077  -0.270, 0.117 -0.060  -0.188, 0.067 0.97 
Model 2 11 or younger  1,266 3.657  1.070 0.209  0.085, 0.334 0.048  -0.020, 0.115 0.13 
12-13 3,675 3.530  1.050 Ref  Ref  NA 
14-15 1,806 3.514  1.032 -0.011  -0.119, 0.097 -0.101  -0.161, -0.041 0.28 
16 or higher 308 3.574  1.001 -0.086  -0.280, 0.107 -0.066  -0.194, 0.061 0.95 
Model 3 11 or younger  1,101 3.641  1.076 0.142  0.006, 0.279 0.065  -0.006, 0.135 0.49 
12-13 3,173 3.503  1.044 Ref  Ref  NA 
14-15 1,546 3.477  1.020 -0.036  -0.157, 0.086 -0.084  -0.147, -0.021 0.57 
16 or higher 265 3.536  0.989 -0.109  -0.321, 0.102 -0.079  -0.213, 0.054 0.94 
Glucose, 
(mmol/L)* 
 
 
Model 1 11 or younger  1,305 4.6  4.3, 4.9 -0.71  -2.21, 0.79 0.82  0.03, 1.61 0.20 
12-13 3,780 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,864 4.6  4.3, 4.8 1.11  -0.16, 2.37 -0.54  -1.25, 0.17 0.12 
16 or higher 324 4.6   4.3, 4.8 -0.64  -3.72, 2.43 -1.08  -2.59, 0.43 0.99 
Model 2 11 or younger  1,305 4.6  4.3, 4.9 -0.73  -2.22, 0.77 0.80  0.01, 1.59 0.18 
12-13 3,780 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,864 4.6  4.3, 4.8 1.13  -0.14, 2.40 -0.54 -1.25, 0.17 0.12 
16 or higher 324 4.6    4.3, 4.8 -0.76 -3.86, 2.34 -1.01 -2.52, 0.50 0.94 
Model 3 11 or younger  1,120 4.6  4.3, 4.9 -0.47 -2.20, 1.25 1.01  0.18, 1.83 0.25 
12-13 3,255 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,593 4.6    4.3, 4.8 1.36  -0.14, 2.86 -0.37  -1.11, 0.37 0.16 
16 or higher 274 4.6  4.3, 4.8 -2.64  -6.33, 1.04 -0.55  -2.13, 1.02 0.51 
CI=confidence interval; HDL=high-density lipoprotein; SD=standard deviation. 
Model 1 Adjusted for age 
Model 2 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease and parental history of diabetes.  
Model 3 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease, parental history of diabetes, smoking, alcohol intake and leisure time physical activity.  
* Outcome log transformed and the coefficients reflect the percent change in the outcome.   
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Table S7. Associations of Age at Menarche With Blood Pressure, Cholesterol and Glucose After Adjustment for Body-Mass Index, the Scottish Family 
Health Study, 2006-2011. 
Outcome Model Age at 
menarche 
N Mean /Median  SD/Range Within-sibships 
association 
Between-sibships 
association 
Bootstrap p-value for 
the difference in the 
within and between 
sibship association 
β  95% CI β  95% CI  
Systolic 
blood 
pressure 
(mmHg) 
Model 1 11 or younger  1,189 127.3  17.2 2.26  -0.26, 4.78 1.74  0.68, 2.80 0.78 
12-13 3,474 124.7  16.3 Ref  Ref  NA 
14-15 1,687 125.1  17.3 0.44  -1.45, 2.32 -0.41 -1.35, 0.53 0.54 
16 or higher 285 126.1  17.4 -2.74  -6.52, 1.04 0.31  -1.69, 2.32 0.34 
Model 2 11 or younger  1,174 127.37 17.19 0.62  -1.88, 3.12 0.55  -0.48, 1.58 0.94 
12-13 3,448 124.71 16.26 Ref  Ref  NA 
14-15 1,674 125.14 17.32 1.10  -0.71, 2.92 0.53 -0.38, 1.45 0.65 
16 or higher 280 126.25 17.50 -1.38  -5.10, 2.34 1.05 -0.90, 2.99 0.48 
Diastolic 
blood 
pressure 
(mmHg) 
Model 1 11 or younger  1,392 79.2  10.1 1.74  0.22, 3.25 1.39  0.71, 2.08 0.75 
12-13 4,034 77.5  9.9 Ref  Ref  NA 
14-15 1,989 77.1  10.0 -0.37  -1.52, 0.78 -0.66  -1.27, -0.05 0.67 
16 or higher 339  77.8  10.1 -0.93  -3.40, 1.54 -0.06  -1.36, 1.24 0.74 
Model 2 11 or younger  1,174 79.2  10.0 0.52  -0.96, 1.99 0.34  -0.30, 0.99 0.84 
12-13 3,448 77.4  9.8 Ref  Ref  NA 
14-15 1,674 77.0  10.1 0.14  -0.96, 1.23 0.14  -0.43, 0.72 0.91 
16 or higher 280 78.0  10.2 0.55  -1.76, 2.86 0.58  -0.64, 1.80 0.87 
HDL 
cholesterol, 
(mmol/L) 
Model 1 11 or younger  1,338 1.537  0.404 -0.042  -0.093, 0.008 -0.038 -0.067, -0.009 0.96 
12-13 3,851 1.591  0.418 Ref  Ref  NA 
14-15 1,897 1.627  0.405 -0.009  -0.057, 0.039 0.037  0.011, 0.063 0.22 
16 or higher 326 1.646  0.432 -0.017  -0.105, 0.071 0.061  0.005, 0.116 0.24 
Model 2 11 or younger  1,132 1.549  0.404 -0.005  -0.054, 0.045 0.002  -0.026, 0.030 0.87 
12-13 3,292 1.605  0.415 Ref  Ref  NA 
14-15 1,602 1.639  0.408 -0.026  -0.071, 0.020 0.007  -0.018, 0.032 0.38 
16 or higher 271 1.673  0.438 -0.037  -0.126, 0.052 0.030  -0.023, 0.083 0.30 
Non-HDL 
cholesterol 
(mmol/L) 
Model 1 11 or younger  1,338 3.638  1.065 0.142  0.009, 0.274 0.068  -0.002, 0.137 0.49 
12-13 3,851 3.517  1.050 Ref  Ref  NA 
14-15 1,897 3.498  1.031 -0.013  -0.132, 0.105 -0.092  -0.154, -0.030 0.37 
16 or higher 326 3.583  1.008 0.071  -0.281, 0.139 -0.070  -0.201, 0.061 0.96 
Model 2 11 or younger  1,132 3.631  1.067 0.038  -0.091, 0.167 -0.006  -0.074, 0.062 0.68 
12-13 3,292 3.491  1.039 Ref  Ref   NA 
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14-15 1,602 3.460  1.023 0.010  -0.106, 0.126 -0.041  -0.102, 0.020 0.55 
16 or higher 271 3.544  1.005 0.005  -0.202, 0.212 -0.028  -0.157, 0.100 0.78 
Glucose, 
(mmol/L)* 
 
 
Model 1 11 or younger  1,317 4.6  4.3, 4.9 -0.022  -2.002, 1.958 1.006  0.125, 1.888 0.43 
12-13 3,814 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,876 4.6  4.3, 4.8 1.534  0.021, 3.047 -0.212  -0.999, 0.576 0.17 
16 or higher 327 4.6  4.3, 4.8 -2.585  -6.208, 1.038 -0.721  -2.396, 0.953 0.54 
Model 2 11 or younger  1,112 4.6    4.3, 4.9 -1.125  -3.057, 0.808 0.516  -0.372, 1.403 0.26 
12-13 3,259 4.5  4.3, 4.8 Ref  Ref   NA 
14-15 1,586  4.6  4.3, 4.8 1.500  0.047, 2.953 0.108  -0.681, 0.897 0.27 
16 or higher 271 4.6  4.3, 4.8 -2.023  -5.570, 1.524 -0.230  -1.902, 1.443 0.58 
CI=confidence interval; HDL=high-density lipoprotein; SD=standard deviation. 
 
Model 1 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease, parental history of diabetes, smoking, alcohol intake and leisure time physical activity. Blood 
pressure further adjusted for use of antihypertensive drugs, cholesterol levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs (Model 3 from Supplement 
Table 4). 
Model 2 Adjusted for all covariates in model 1 in addition to adult body-mass index.  
*Outcomes log transformed and the coefficients reflect the percent change in the outcome.  
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Table S8. Association Between Age at Menarche and 10-Year Risk for Cardiovascular Disease After Adjustment for Adult Body-Mass Index, 
the Scottish Family Health Study, 2006-2011. 
 
Risk score Model Age at menarche N Mean SD Within-sibships 
association 
Between-sibships 
association 
Bootstrap p-value for 
the difference in the 
within and between 
sibship association 
β  95% CI β  95% CI  
Framingham 
risk score * 
Model 1 11 or younger  922 26.04  0.90 0.08  -0.01, 0.17 0.08  0.04, 0.13 0.85 
12-13 2,591 25.92  0.89 Ref  Ref  NA 
14-15 1,312 25.94  0.91 0.02  -0.05, 0.09 -0.02  -0.06, 0.01 0.40 
16 or higher 231 26.01  0.84 -0.04  -0.18, 0.10 0.01  -0.07, 0.08 0.71 
Model 2 11 or younger  913 26.04  0.90 0.00  -0.08, 0.09 0.02  -0.02, 0.06 0.78 
12-13 2,575 25.92  0.89 Ref  Ref  NA 
14-15 1,304 25.94  0.91 0.04  -0.02, 0.11 0.02  -0.01, 0.06 0.67 
16 or higher 227 26.02  0.84 0.02  -0.11, 0.14 0.04  -0.03, 0.11 0.91 
NHANES 
ECG risk 
equation † 
Model 1 11 or younger  919 7.957  0.846 0.044  0.005, 0.083 0.023  0.006, 0.041 0.43 
12-13 2,625 7.914  0.845 Ref  Ref  NA 
14-15 1,336 7.928  0.865 -0.015  -0.047, 0.017 -0.014  -0.030, 0.001 0.93 
16 or higher 224 8.025  0.783 -0.001  -0.073, 0.071 0.027  -0.005, 0.060 0.79 
Model 2 11 or younger  909 7.961  0.848 0.022  -0.016, 0.059 0.004  -0.014, 0.021 0.45 
12-13 2,607 7.913  0.844 Ref  Ref  NA 
14-15 1,328 7.929  0.864 -0.006  -0.037, 0.026 0.000  -0.015, 0.015 0.94 
16 or higher 220 8.029  0.786 0.005  -0.064, 0.074 0.034  0.002, 0.065 0.75 
CI=confidence interval; ECG=electrocardiogram; SD=standard deviation. 
 
* The variables included in the Framingham risk score is age, total cholesterol, HDL cholesterol, systolic blood pressure, smoking and diabetes.  
† The information included in the NHANES ECG risk score included age, positive deflection of T axis, negative deflection of the T axis, heart rate and corrected QT interval.   
Model 1 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease, parental history of diabetes, smoking, alcohol intake and leisure time physical activity (Model 3 
from Table 2). 
Model 2 Adjusted for all covariates in model 1 in addition to adult body-mass index.  
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Table S9. Association Between Age at Menarche and Cardiometabolic Health After Restricting the Analysis to Sibships With up to Four Years Age 
Difference Between Sisters, the Scottish Family Health Study, 2006-2011. 
Outcome Model Age at 
menarche 
N Mean/Median  SD/Range Within-sibships association Between-sibships association  Bootstrap p-value for the 
difference in the within and 
between sibship association 
β  95% CI β  95% CI  
Systolic blood 
pressure (mmHg) 
Model 1 11 or younger  1,276 127.4  17.1 2.67  0.14, 5.20 1.87  0.84, 2.90 0.69 
12-13 3,757 124.9  16.6 Ref  Ref  NA 
14-15 1,855 125.9  17.8 1.20  -0.76, 3.15 -0.26  -1.17, 0.65 0.25 
16 or higher 313 126.6  18.4 -2.46  -6.58, 1.67 0.28  -1.67, 2.22 0.41 
Model 2 11 or younger  1,276 127.4  17.1 2.35  -0.19, 4.88 1.53  0.52, 2.55 0.70 
12-13 3,757 124.9  16.6 Ref  Ref  NA 
14-15 1,855 125.9  17.8 1.24  -0.71, 3.20 -0.20  -1.09, 0.70 0.27 
16 or higher 313 126.6  18.4 -2.50  -6.65, 1.66 0.26  -1.66, 2.18 0.41 
Model 3 11 or younger  1,090 127.2  17.1 3.01  0.09, 5.93 1.60  0.53, 2.67 0.58 
12-13 3,235 124.7  16.3 Ref  Ref  NA 
14-15 1,569 125.4  17.5 1.75  -0.45, 3.93 -0.24  -1.20, 0.71 0.19 
16 or higher 266 126.2  17.8 1.74 -0.45, 3.93 0.05  -1.98, 2.08 0.29 
Diastolic blood 
pressure (mmHg) 
Model 1 11 or younger  1,276 79.2  10.0 1.53  0.03, 3.03 1.38 0.72, 2.03 0.89 
12-13 3,757 77.5  9.9 Ref  Ref  NA 
14-15 1,855 77.1  10.1 0.06  -1.15, 1.26 -0.77 -1.34, -0.19 0.27 
16 or higher 313 77.6  10.2 -0.27  -2.94, 2.40 -0.56  -1.79, 0.68 0.79 
Model 2 11 or younger  1,276 79.2  10.0 1.30  -0.19, 2.79 1.22 0.57, 1.87 0.95 
12-13 3,757 77.5  9.9 Ref  Ref   NA 
14-15 1,855 77.1  10.1 0.07  -1.13, 1.28 -0.74 -1.32, -0.17 0.27 
16 or higher 313 77.6  10.2 -0.30  -2.98, 2.37 -0.55  -1.78, 0.68 0.80 
Model 3 11 or younger  1,090 79.1  10.1 1.93  0.21, 3.66 1.31  0.62, 2.00 0.67 
12-13 3,235 77.3  9.9 Ref  Ref  NA 
14-15 1,569 77.0  10.2 0.30  -1.03, 1.63 -0.63  -1.24, -0.01 0.27 
16 or higher 266 77.7  10.5 -1.08  -4.10, 1.93 -0.18  -1.49, 1.14 0.75 
HDL cholesterol, 
(mmol/L) 
Model 1 11 or younger  1,228 1.534 0.405 -0.061  -0.114, -0.008 -0.049 -0.078, -0.020 0.81 
12-13 3,591 1.589 0.414 Ref  Ref  NA 
14-15 1,768 1.625  0.406 -0.022  -0.069, 0.026 0.038 0.013, 0.064 0.08 
16 or higher 300 1.661  0.436 -0.037  -0.139, 0.061 0.073 0.018, 0.127 0.14 
Model 2 11 or younger  1,228 1.534  0.405 -0.061  -0.114, -0.007 -0.042  -0.070, -0.014 0.68 
12-13 3,591 1.589  0.414 Ref  Ref  NA 
14-15 1,768 1.625  0.406 -0.02 -0.071, 0.024 0.039 0.014, 0.065 0.07 
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16 or higher 300 1.661  0.436 -0.036  -0.137, 0.065 0.083 0.029, 0.137 0.12 
Model 3 11 or younger  1,053 1.546  0.406 -0.036  -0.097, 0.025 -0.040 -0.069, -0.010 0.88 
12-13 3,089 1.603  0.410 Ref  Ref  NA 
14-15 1,500 1.638  0.409 -0.022  -0.076, 0.032 0.035  0.008, 0.061 0.15 
16 or higher 257 1.684  0.441 -0.024  -0.122, 0.074 0.073 0.017, 0.128 0.20 
Non-HDL 
cholesterol 
(mmol/L) 
Model 1 11 or younger  1,228 3.630  1.056 0.159  0.009, 0.309 0.070 0.002, 0.138 0.49 
12-13 3,591 3.518  1.057 Ref  Ref  NA 
14-15 1,768 3.491  1.025 -0.006  -0.132, 0.120 -0.089 -0.149, -0.028 0.27 
16 or higher 300 3.568  0.996 -0.072  -0.295, 0.151 -0.049  -0.178, 0.080 0.99 
Model 2 11 or younger  1,228 3.630  1.056 0.154  0.009, 0.299 0.055  -0.012, 0.122 0.42 
12-13 3,591 3.518  1.057 Ref  Ref  NA 
14-15 1,768 3.491  1.025 -0.008  -0.130, 0.114 -0.098 -0.157, -0.039 0.24 
16 or higher 300 3.568  0.996 -0.067  -0.273, 0.139 -0.067  -0.193, 0.059 0.94 
Model 3 11 or younger  1,053 3.619  1.059 0.115  -0.046, 0.276 0.059 -0.011, 0.129 0.70 
12-13 3,089 3.490  1.044 Ref  Ref  NA 
14-15 1,500 3.452  1.013 -0.031  -0.166, 0.104 -0.088 -0.150, -0.026 0.49 
16 or higher 257 3.525  0.979 -0.082  -0.314, 0.151 -0.100  -0.232, 0.033 0.85 
Glucose, 
(mmol/L)* 
 
 
Model 1 11 or younger  1,207 4.6  4.3, 4.9 -0.62  -2.49, 1.24 1.24  0.34, 2.15 0.19  
12-13 3,555 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,747 4.6  4.3, 4.8 -0.22  -1.83, 1.40 -0.20 -1.01, 0.60 0.94 
16 or higher 301 4.6  4.3, 4.8 -3.06  -6.54, 0.43 -0.59  -2.30, 1.13 0.32 
Model 2 11 or younger  1,207 4.6  4.3, 4.9 -0.51  -2.32, 1.30 1.10  0.24, 1.97 0.22 
12-13 3,555 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,747 4.6  4.3, 4.8 0.02  -1.53, 1.56 -0.12  -0.88, 0.65 0.98 
16 or higher 301 4.6  4.3, 4.8 -3.08  -6.61, 0.45 -0.59  -2.23, 1.05 0.29 
Model 3 11 or younger  1,033 4.6  4.3, 4.8 0.02  -2.02, 2.05 0.94 0.03, 1.84 0.50 
12-13 3,057 4.5  4.3, 4.9 Ref  Ref  NA 
14-15 1,484 4.6  4.3, 4.8 0.84  -0.86, 2.53 -0.16  -0.97, 0.65 0.48 
16 or higher 257 4.6  4.3, 4.8 -4.14  -8.69, 0.42 -0.57  -2.28, 1.14 0.32 
Body-mass index 
(kg/m2)  
Model 1 11 or younger  1,260 28.0 6.1 1.70  0.87, 2.52 1.88  1.52, 2.25 0.73 
12-13 3,721 26.1  5.2 Ref  Ref  NA 
14-15 1,842 25.1  4.8 -0.43  -1.02, 0.17 -1.24  -1.56, -0.92 0.05 
16 or higher 309 25.3  5.3 -0.86  -2.05, 0.34 -1.15  -1.84, -0.47 0.87 
Model 2 11 or younger  1,260 28.0  6.1 1.60  0.78, 2.42 1.76  1.40, 2.11 0.77 
12-13 3,721 26.1  5.2 Ref  Ref  NA 
14-15 1,842 25.1  4.8 -0.42  -1.02, 0.18 -1.24  -1.55, -0.93 0.05 
16 or higher 309 25.3  5.3 -0.87  -2.05, 0.32 -1.29  -1.96, -0.62 0.75 
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Model 3 11 or younger  1,078 27.8  6.0 1.95  1.09, 2.82 1.68  1.31, 2.05 0.70 
12-13 3,213 25.9  5.0 Ref  Ref  NA 
14-15 1,559 24.9  4.6 -0.75  -1.39, -0.12 -1.12 -1.45, -0.79 0.43 
16 or higher 263 25.0  5.2 -1.73  -2.97, -0.49 -1.13 -1.83, -0.44 0.45 
Waist 
circumference, 
(cm) 
Model 1 11 or younger  1,249 88.1  15.2 3.07 0.98, 5.18 3.66  2.71, 4.60 0.67 
12-13 3,707 84.4  13.8 Ref  Ref  NA 
14-15 1,833 82.5  12.8 -0.64 -2.37, 1.09 -2.53 -3.36, -1.70 0.13 
16 or higher 309 83.2  14.1 -2.67  -5.75, 0.40 -1.87 -3.64, -0.09 0.71 
Model 2 11 or younger  1,249 88.1  15.2 2.89  0.79, 4.99 3.30 2.37, 4.23 0.76 
12-13 3,707 84.4  13.8 Ref  Ref  NA 
14-15 1,833 82.5  12.8 -0.67  -2.41, 1.06 -2.58  -3.40, -1.77 0.13 
16 or higher 309 83.2  14.1 -2.65  -5.70, 0.40 -2.26  -4.01, -0.51 0.84 
Model 3 11 or younger  1,067 87.7  14.9 3.30  1.15, 5.45 3.16  2.19, 4.13 0.92 
12-13 3,200 83.9  13.4 Ref  Ref  NA 
14-15 1,555 82.0  12.3 -1.23  -2.95, 0.50 -2.43  -3.29, -1.58 0.33 
16 or higher 263 82.5  13.5 -3.72  -6.63, -0.81 -2.18 -4.00, -0.35 0.48 
CI=confidence interval; HDL=high-density lipoprotein; SD=standard deviation. 
Model 1 Adjusted for age 
Model 2 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease and parental history of diabetes. Blood pressure further adjusted for use of antihypertensive drugs, 
cholesterol levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs. 
Model 3 Adjusted for all the characteristics in Model 2 in addition to smoking, alcohol intake and leisure time physical activity.  
* Outcome log transformed and the coefficients reflect the percent change in the outcome.  
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Table S10. Association Between Age at Menarche and 10-Year Risk of Cardiovascular Disease After Restricting the Analysis to Sibships With up to Four 
Years Age Difference Between Sisters, the Scottish Family Health Study, 2006-2011 
Risk score Model Age at menarche N Mean SD Within-sibships 
association 
Between-sibships 
association 
Bootstrap p-value for the 
difference in the within and 
between sibship association 
β  95% CI β  95% CI  
Framingham 
risk score * 
Model 1 11 or younger  982 26.06  0.90 0.13  0.05, 0.22 0.09  0.05, 0.13 0.67 
12-13 2,795 25.95  0.90 Ref  Ref  NA 
14-15 1,430 25.98  0.93 0.04  -0.03, 0.11 -0.03 -0.06, 0.01 0.21 
16 or higher 248 26.07  0.90 -0.08  -0.21, 0.05 0.03  -0.05, 0.11 0.28 
Model 2 11 or younger  982 26.06 0.90 0.12  0.03, 0.21 0.08  0.04, 0.12 0.66 
12-13 2,795 25.95  0.90 Ref  Ref  NA 
14-15 1,430 25.98  0.93 0.04  -0.03, 0.11 -0.03 -0.06, 0.01 0.18 
16 or higher 248 26.07  0.90 -0.07  -0.21, 0.06 0.01  -0.06, 0.09 0.42 
Model 3 11 or younger  843 26.04 0.90 0.12  0.02, 0.22 0.08  0.03, 0.12 0.72 
12-13 2,400 25.92  0.90 Ref  Ref  NA 
14-15 1,211 25.95  0.92 0.04  -0.03, 0.12 -0.02 -0.06, 0.02 0.27 
16 or higher 214 26.02  0.86 -0.08  -0.23, 0.07 0.00  -0.08, 0.08 0.47 
NHANES 
ECG risk 
equation † 
Model 1 11 or younger  981 7.97  0.86 0.04  0.00, 0.08 0.02  0.00, 0.04 0.41 
12-13 2,830 7.93  0.85 Ref  Ref  NA 
14-15 1,464 7.98  0.89 -0.01 -0.04, 0.02 -0.01 -0.03, 0.00 0.84 
16 or higher 243 8.08  0.83 -0.02 -0.09, 0.06 0.03  0.00, 0.06 0.49 
Model 2 11 or younger  981 7.97  0.86 0.04  0.00, 0.08 0.02  0.00, 0.03 0.35 
12-13 2,830 7.93 0.85 Ref  Ref  NA 
14-15 1,464 7.98  0.89 -0.01 -0.04, 0.02 -0.01 -0.03, 0.00 0.77 
16 or higher 243 8.08  0.83 -0.02 -0.09, 0.06 0.03  0.00, 0.06 0.54 
Model 3 11 or younger  838 7.97  0.86 0.05  0.01, 0.10 0.02  0.01, 0.04 0.36 
12-13 2,433 7.92  0.85 Ref  Ref  NA 
14-15 1,233 7.94  0.87 -0.03 -0.07, 0.01 -0.01 -0.03, 0.00 0.63 
16 or higher 208 8.03  0.80 -0.02 -0.11, 0.07 0.03  -0.01, 0.06 0.53 
CI=confidence interval; ECG=electrocardiogram; SD=standard deviation. 
* The variables included in the Framingham risk score is age, total cholesterol, HDL cholesterol, systolic blood pressure, smoking and diabetes.  
† The information included in the NHANES ECG risk score included age, positive deflection of T axis, negative deflection of the T axis, heart rate and corrected QT interval. 
The estimates are from a mixed effects linear regression analysis. 
Model 1 Adjusted for age 
Model 2 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease and parental history of diabetes. 
Model 3 Adjusted for all of the covariates in Model 2 in addition to smoking (not adjusted for in the analysis of the NHANES risk score since part of the risk calculation), alcohol intake and 
leisure time physical activity. 
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Table S11. Association Between Age at Menarche and Cardiometabolic Health Outcomes Excluding Individuals of Non-European Ethnicity, the Scottish 
Family Health Study, 2006-2011. 
 
Outcome Model Age at menarche N Mean/Median  SD/Range Within-sibships 
association 
Between-sibships 
association 
Bootstrap p-value for the 
difference in the within and 
between sibship association 
β 95% CI β 95% CI  
Systolic blood 
pressure (mmHg) 
Model 1 11 or younger  1,362 127.7 17.2 1.95  -0.19, 4.08 2.15 1.12, 3.18 0.98 
12-13 3,959 124.9  16.5 Ref  Ref  NA 
14-15 1,943 125.7  17.6 -0.05 -1.71, 1.61 -0.45 -1.36, 0.47 0.69 
16 or higher 334 126.6  18.0 -2.56 -6.09, 0.96 0.87  -1.08, 2.82 0.33 
Model 2 11 or younger  1,362 127.7 17.2 1.82  -0.33, 3.97 1.82  0.75, 2.89 0.91 
12-13 3,959 124.9  16.5 Ref  Ref  NA 
14-15 1,943 125.7  17.6 -0.03 -1.70, 1.64 -0.34  -1.29, 0.62 0.75 
16 or higher 334 126.6  18.0 -2.63 -6.16, 0.90 0.45  -1.57, 2.48 0.32 
Model 3 11 or younger  1,165 127.4  17.3 2.35  -0.19, 4.88 1.74  0.68, 2.80 0.74 
12-13 3,408 124.7  16.3 Ref  Ref  NA 
14-15 1,649 125.2  17.3 0.35  -1.57, 2.26 -0.41  -1.35, 0.53 0.58 
16 or higher 281 126.2  17.4 -3.02 -6.85, 0.81 0.31  -1.69, 2.32 0.29 
Diastolic blood 
pressure (mmHg) 
Model 1 11 or younger  1,362 79.2  10.1 1.42  0.14, 2.70 1.49  0.84, 2.15 0.98 
12-13 3,959 77.5  9.9 Ref  Ref  NA 
14-15 1,943 77.1  10.0 -0.62 -1.64, 0.41 -0.84  -1.43, -0.26 0.69 
16 or higher 334 77.8  10.1 -0.41 -2.55, 1.73 -0.22  -1.47, 1.02 0.97 
Model 2 11 or younger  1,362 79.2  10.1 1.38  0.09, 2.66 1.33  0.69, 1.98 0.89 
12-13 3,959 77.5  9.9 Ref  Ref  NA 
14-15 1,943 77.1  10.0 -0.62 -1.64, 0.41 -0.80  -1.38, -0.22 0.74 
16 or higher 334 77.8  10.1 -0.45 -2.61, 1.70 -0.20  -1.44, 1.03 0.99 
Model 3 11 or younger  1,165 79.2  10.1 1.81  0.29, 3.33 1.41  0.72, 2.10 0.67 
12-13 3,408 77.4  9.8 Ref  Ref  NA 
14-15 1,649 77.0  10.1 -0.47 -1.63, 0.69 -0.60  -1.21, 0.02 0.77 
16 or higher 281 77.9  10.3 -1.02 -3.52, 1.48 -0.09  -1.22, 1.40 0.65 
HDL cholesterol, 
(mmol/L) 
Model 1 11 or younger  1,309 1.538  0.405 -0.065  -0.110, -0.019 -0.045  -0.074, -0.016 0.62 
12-13 3,779 1.592  0.418 Ref  Ref  NA 
14-15 1,854 1.631  0.402 -0.009 -0.051, 0.033 0.044  0.018, 0.070 0.10 
16 or higher 
 
321 1.645 0.433 -0.032 -0.118, 0.053 0.059  0.004, 0.114 0.18 
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Model 2 11 or younger  1,309 1.538  0.405 -0.061 -0.106, -0.016 -0.037 -0.066, -0.009 0.53 
12-13 3,779 1.592  0.418 Ref  Ref  NA 
14-15 1,854 1.631  0.402 -0.010 -0.052, 0.032 0.045  0.019, 0.070 0.10 
16 or higher 321 1.645 0.433 -0.032 -0.118, 0.053 0.067  0.013, 0.120 0.14 
Model 3 11 or younger  1,122 1.551  0.405 -0.042 -0.094, 0.009 -0.038  -0.067, -0.008 0.93 
12-13 3,251 1.605  0.415 Ref  Ref  NA 
14-15 1,580 1.644  0.405 -0.011  -0.059, 0.038 0.040  0.014, 0.066 0.18 
16 or higher 272 1.674  0.440 -0.028  -0.116, 0.061 0.062 0.006, 0.117 0.20 
Non-HDL 
cholesterol 
(mmol/L) 
Model 1 11 or younger  1,309 3.636  1.064 0.209 0.086, 0.332 0.065  -0.003, 0.132 0.17 
12-13 3,779 3.509 1.046 Ref  Ref  NA 
14-15 1,854 3.496 1.031 0.034  -0.074, 0.142 -0.093 -0.154, -0.033 0.11 
16 or higher 321 3.586 1.008 -0.025 -0.229, 0.179 -0.011  -0.140, 0.118 0.98 
Model 2 11 or younger  1,309 3.636  1.064 0.213  0.094, 0.331 0.053  -0.014, 0.119 0.11 
12-13 3,779 3.509 1.046 Ref  Ref  NA 
14-15 1,854 3.496 1.031 0.025  -0.079, 0.128 -0.098  -0.157, -0.038 0.12 
16 or higher 321 3.586 1.008 -0.019 -0.207, 0.168 -0.035  -0.161, 0.092 0.88 
Model 3 11 or younger  1,122 3.625 1.067 0.152 0.021, 0.284 0.067  -0.003, 0.137 0.42 
12-13 3,251 3.483 1.034 Ref  Ref  NA 
14-15 1,580 3.462 1.021 0.00002 -0.120, 0.120 -0.083  -0.145, -0.020 0.35 
16 or higher 272 3.547 1.002 0.062  -0.280, 0.151 -0.055 -0.188, 0.077 0.96 
Glucose, 
(mmol/L)* 
 
 
Model 1 11 or younger  1,289 4.6 4.3, 4.9 -0.721 -2.422, 0.980 1.376  0.474, 2.277 0.11 
12-13 3,741 4.5 4.3, 4.8 Ref  Ref  NA 
14-15 1,832 4.6 4.3, 4.8 0.767  -0.632, 2.165 -0.429 -1.237, 0.380 0.32 
16 or higher 322 4.6  4.3, 4.8 -0.681 -3.770, 2.407 -0.840  -2.550, 0.870 0.91 
Model 2 11 or younger  1,289 4.6  4.3, 4.9 -0.291 -1.936, 1.354 1.143  0.280, 2.006 0.25 
12-13 3,741 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,832 4.6  4.3, 4.8 0.886  -0.464, 2.235 -0.317 -1.090, 0.455 0.30 
16 or higher 322 4.6  4.3, 4.8 -0.796 -3.942, 2.349 -0.917  -2.553, 0.718 0.88 
Model 3 11 or younger  1,103 4.6  4.3, 4.9 0.008 -1.986, 2.001 1.010 0.121, 1.890 0.44 
12-13 3,217 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,563 4.6  4.3, 4.8 1.462 -0.071, 2.994 -0.288  -1.083, 0.507 0.17 
16 or higher 272 4.6  4.3, 4.8 -2.570 -6.233, 1.093 -0.752  -2.434, 0.930 0.54 
Body-mass index 
(kg/m2)  
Model 1 11 or younger  1,344 28.080  6.176 1.710 1.018, 2.401 1.848  1.481, 2.214 0.74 
12-13 3,922 26.115  5.212 Ref  Ref  NA 
14-15 1,929 25.061 4.767 -0.456 -0.961, 0.049 -1.335  -1.660, -1.009 0.02 
16 or higher 
 
329 25.423 5.402 -0.667 -1.726, 0.392 -1.057 -1.752, -0.361 0.76 
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Model 2 11 or younger  1,344 28.080  6.176 1.653  0.970, 2.335 1.718  1.358, 2.078 0.84 
12-13 3,922 26.115  5.212 Ref  Ref  NA 
14-15 1,929 25.061 4.767 -0.452 -0.961, 0.057 -1.330 -1.650, -1.010 0.02 
16 or higher 329 25.423 5.402 -0.672 -1.724, 0.380 -1.186  -1.870, -0.503 0.65 
Model 3 11 or younger  1,122 3.625 1.067 1.736  0.985, 2.488 1.642  1.270, 2.014 0.93 
12-13 3,251 3.483  1.035 Ref  Ref  NA 
14-15 1,580 3.462  1.022 -0.628 -1.187, -0.069 -1.237  -1.569, -0.906 0.16 
16 or higher 272 3.547 1.002 -1.429 -2.545, -0.313 -0.956  -1.660, -0.251 0.55 
Waist 
circumference, 
(cm) 
Model 1 11 or younger  1,334 88.23  15.33 3.004  1.301, 4.707 3.513  2.559, 4.467 0.61 
12-13 3,906 84.50  13.82 Ref  Ref  NA 
14-15 1,920 82.54  12.69 -0.767 -2.171, 0.638 -2.730  -3.579, -1.881 0.06 
16 or higher 335 83.68 14.56 -1.938 -4.651, 0.776 -1.621 -3.427, 0.184 0.83 
Model 2 11 or younger  1,334 88.23  15.33 2.927  1.237, 4.616 3.155  2.217, 4.094 0.77 
12-13 3,906 84.50  13.82 Ref  Ref  NA 
14-15 1,920 82.54  12.69 -0.775 -2.181, 0.631 -2.761  -3.595, -1.926 0.06 
16 or higher 335 83.68 14.56 -1.909 -4.616, 0.797 -2.018 -3.794, -0.241 0.96 
Model 3 11 or younger  1,142 87.65 14.99 2.716  0.936, 4.498 3.056  2.085, 4.027 0.79 
12-13 3,371 84.08 13.50 Ref  Ref  NA 
14-15 1,634 81.95 12.15 -1.266 -2.745, 0.212 -2.638  -3.503, -1.773 0.22 
16 or higher 278 83.07  13.97 -3.056 -5.683, -0.429 -1.656  -3.495, 0.183 0.52 
 
CI=confidence interval; HDL=high-density lipoprotein; SD=standard deviation. 
 
Model 1 Adjusted for age 
Model 2 Adjusted for age, qualifications, parental history of cardiovascular disease and parental history of diabetes. Blood pressure further adjusted for use of antihypertensive drugs, cholesterol 
levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs. 
Model 3 Adjusted for age, qualifications, parental history of cardiovascular disease, parental history of diabetes, smoking, alcohol intake and leisure time physical activity. Blood pressure 
further adjusted for use of antihypertensive drugs, cholesterol levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs. 
 
* Outcome log transformed and the coefficients reflect the percent change in the outcome.  
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Table S12. Association Between Age at Menarche and 10-Year Risk For Overall Cardiovascular Disease Excluding Individuals of Non-European ethnicity, 
the Scottish Family Health Study, 2006-2011.   
Risk score Model Age at menarche N Mean SD Within-sibships association  Between-sibships association Bootstrap p-value for the 
difference in the within and 
between sibship association 
β  95% CI β  95% CI  
Framingham 
risk score * 
Model 1 11 or younger  1,051 26.07 0.90 0.10 0.02, 0.17 0.11  0.06, 0.15 0.80 
12-13 2,956 25.94 0.90 Ref  Ref  NA 
14-15 1,504 25.97 0.92 0.02  -0.04, 0.08 -0.03 -0.07, 0.003 0.24 
16 or higher 267 26.07 0.86 -0.03  -0.15, 0.09 0.05  -0.03, 0.13 0.48 
Model 2 11 or younger  1,051 26.07 0.90 0.09 0.01, 0.16 0.09  0.05, 0.13 0.88 
12-13 2,956 25.94 0.90 Ref  Ref  NA 
14-15 1,504 25.97 0.92 0.02  -0.04, 0.08 -0.04  -0.07, -0.002 0.20 
16 or higher 267 26.07 0.86 -0.03 -0.15, 0.10  0.03  -0.04, 0.10 0.63 
Model 3 11 or younger  902 26.04  0.90 0.08  -0.01, 0.17 0.09 0.05, 0.13 0.88 
12-13 2,538 25.92  0.89 Ref  Ref  NA 
14-15 1,280 25.94  0.91 0.02  -0.05, 0.09 -0.02 -0.06, 0.01 0.39 
16 or higher 227 26.02  0.83 -0.04  -0.18, 0.10 0.02  -0.06, 0.09 0.66 
NHANES 
ECG risk 
equation 
score † 
Model 1 11 or younger  1,051 7.971 0.846 0.030  -0.004, 0.064 0.018  0.001, 0.035 0.59 
12-13 2,994 7.931 0.847 Ref  Ref  NA 
14-15 1,544 7.976  0.882 0.005 -0.023, 0.032 -0.019 -0.034, -0.004 0.24 
16 or higher 260 8.056  0.803 0.004 -0.057, 0.065 0.024  -0.008, 0.056 0.85 
Model 2 11 or younger  1,051 7.971 0.846 0.031  -0.004, 0.065 0.016  -0.002, 0.033 0.50 
12-13 2,994 7.931 0.847 Ref  Ref  NA 
14-15 1,544 7.976  0.882 0.006  -0.022, 0.033 -0.019  -0.034, -0.004 0.22 
16 or higher 260 8.056  0.803 0.004  -0.057, 0.066 0.022  -0.010, 0.054 0.89 
Model 3 11 or younger  899 7.966  0.846 0.043  0.004, 0.082 0.023  0.006, 0.041 0.46 
12-13 2,571 7.918  0.847 Ref  Ref  NA 
14-15 1,306 7.935 0.866 -0.016  -0.048, 0.016 -0.013 -0.029, 0.003 1.00 
16 or higher 220 8.024 0.765 -0.002  -0.075, 0.071 0.024  -0.008, 0.057 0.80 
CI=confidence interval; ECG=electrocardiogram; SD=standard deviation. 
* The variables included in the Framingham risk score is age, total cholesterol, HDL cholesterol, systolic blood pressure, smoking and diabetes.  
† The information included in the NHANES ECG risk score included age, positive deflection of T axis, negative deflection of the T axis, heart rate and corrected QT interval.   
Model 1 Adjusted for age 
Model 2 Adjusted for age, qualifications, parental history of cardiovascular disease and parental history of diabetes.  
Model 3 Adjusted for all of the covariates in Model 2 in addition to smoking (not adjusted for in the analysis of the Framingham risk score since part of the risk calculation), alcohol intake and 
leisure time physical activity. 
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Table S13. Association Between Age at Menarche and Cardiometabolic Health Outcomes Excluding Non-fasting Individuals, the Scottish Family Health 
Study, 2006-2011. 
 
Outcome Model Age at 
menarche 
N Mean/
Median  
SD/Range Within-sibships 
association 
Between-sibships 
association 
Bootstrap p-value for the 
difference in the within and 
between sibship association 
β 95% CI β 95% CI  
HDL cholesterol, 
(mmol/L) 
Model 1 11 or younger  1,139 1.543  0.411 -0.075  -0.127, -0.024 -0.038  -0.069, -0.008 0.37 
12-13 3,275 1.591  0.414 Ref  Ref  NA 
14-15 1,599 1.623 0.403 -0.030 -0.078, 0.018 0.039  0.011, 0.066 0.07 
16 or higher 274 1.631 0.429 -0.027 -0.117, 0.062 0.048  -0.009, 0.105 0.30 
Model 2 11 or younger  1,139 1.543  0.411 -0.077 -0.128, -0.025 -0.029 -0.059, 0.001 0.24 
12-13 3,275 1.591  0.414 Ref  Ref  NA 
14-15 1,599 1.623 0.403 -0.031 -0.079, 0.017 0.039  0.012, 0.066 0.06 
16 or higher 274 1.631 0.429 -0.028 -0.118, 0.062 0.057  0.001, 0.114 0.25 
Model 3 11 or younger  971 1.556  0.411 -0.065 -0.125, -0.006 -0.024  -0.055, 0.007 0.39 
12-13 2,809 1.602  0.411 Ref  Ref  NA 
14-15 1,367 1.635  0.408 -0.040  -0.095, 0.015 0.042  0.014, 0.069 0.05 
16 or higher 272 1.652  0.431 -0.045  -0.143, 0.054 0.054 -0.004, 0.112 0.21 
Non-HDL 
cholesterol 
(mmol/L) 
Model 1 11 or younger  1,139 3.630  1.058 0.202 0.064, 0.341 0.047  -0.025, 0.119 0.18 
12-13 3,275 3.530 1.050 Ref  Ref  NA 
14-15 1,599 3.511 1.021 0.059  -0.066, 0.184 -0.099 -0.163, -0.034 0.08 
16 or higher 274 3.589 1.006 -0.057 -0.302, 0.188 -0.028  -0.163, 0.107 0.92 
Model 2 11 or younger  1,139 3.630  1.058 0.204  0.072, 0.337 0.033  -0.038, 0.103 0.11 
12-13 3,275 3.530 1.050 Ref  Ref  NA 
14-15 1,599 3.511 1.021 0.046  -0.075, 0.168 -0.101  -0.164, -0.039 0.10 
16 or higher 274 3.589 1.006 -0.043 -0.267, 0.182 -0.044  -0.176, 0.088 0.98 
Model 3 11 or younger  971 3.619 1.062 0.155 0.003, 0.306 0.042  -0.032, 0.116 0.34 
12-13 2,809 3.510 1.042 Ref  Ref  NA 
14-15 1,367 3.472 1.014 0.055 -0.083, 0.193 -0.104  -0.170, -0.038 0.11 
16 or higher 234 3.560 1.009 -0.075  -0.328, 0.178 -0.046 -0.185, 0.093 0.96 
Glucose, 
(mmol/L)* 
 
 
Model 1 11 or younger  1,125 4.6 4.3, 4.9 -1.351 -2.916, 0.213 1.229 0.398, 2.059 0.04 
12-13 3,248 4.5 4.3, 4.8 Ref  Ref  NA 
14-15 1,583 4.6 4.3, 4.8 -0.095 -1.577, 1.387 -0.504 -1.246, 0.238 0.80 
16 or higher 
 
 
275 
 
4.6  4.3, 4.8 -0.560 -4.375, 3.256 -0.589 -2.153, 0.975 0.87 
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Model 2 11 or younger  1,125 4.6 4.3, 4.9 -0.865 -2.382, 0.653 1.209 0.398, 2.020 0.10 
12-13 3,248 4.5 4.3, 4.8 Ref  Ref  NA 
14-15 1,583 4.6 4.3, 4.8 0.006 -1.385, 1.398 -0.294 -1.019, 0.430 0.81 
16 or higher 275 4.6  4.3, 4.8 -0.682 -4.505, 3.141 -0.437 -1.964, 1.090 0.80 
Model 3 11 or younger  958 4.6  4.3, 4.9 -0.263 -1.966, 1.440 1.087 0.244, 1.930 0.29 
12-13 2,785 4.5  4.3, 4.8 Ref  Ref  NA 
14-15 1,355 4.6  4.3, 4.8 0.479 -1.024, 1.983 -0.332 -1.084, 0.420 0.54 
16 or higher 234 4.6  4.3, 4.8 -3.115 -7.624, 1.394 -0.155 -1.740, 1.430 0.41 
 
CI=confidence interval; HDL=high-density lipoprotein; SD=standard deviation. 
 
Model 1 Adjusted for age 
Model 2 Adjusted for age, ethnicity, qualifications, parental history of cardiovascular disease and parental history of diabetes. Blood pressure further adjusted for use of antihypertensive drugs, 
cholesterol levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs. 
Model 3 Adjusted for age, ethnicity qualifications, parental history of cardiovascular disease, parental history of diabetes, smoking, alcohol intake and leisure time physical activity. Blood 
pressure further adjusted for use of antihypertensive drugs, cholesterol levels adjusted for lipid lowering drugs and glucose adjusted for use of antidiabetic drugs. 
 
* Outcome log transformed and the coefficients reflect the percent change in the outcome.  
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